Literature review reveals satisfactory therapeutic responses to plasmapheresis across immune-mediated neurological diseases, highlighting its critical role in patient quality of life.
Plasmapheresis is a therapeutic apheresis procedure of high complexity, often available only in reference centers.This availability allows the medical team to offer the patient a treatment that has been proven effective for morbidities of major impact from the clinical point of view, reflecting directly on the patient's quality of life.This literature review shows that many immune-mediated neurological diseases have satisfactory therapeutic response to this procedure.Myasthenia gravis, chronic demyelinating inflammatory polyradiculoneuropathy, Guillain-Barré syndrome and multiple sclerosis are the main representatives.
No takes yet. Share an insight, caveat, or question.
Oliveira et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: